Back
ESC Premium Access

Comparative effectiveness and safety between non-VKA oral anticoagulants in non-valvular atrial fibrillation patients: a dose subgroup analysis of the ARISTOPHANES study

Session: Poster Session 3 - Atrial fibrillation - Stroke prevention
Topic: Oral Anticoagulation
Speaker: Doctor X. Li (Princeton, US)
Event: ESC Congress 2018

Congress Presentation

Add to my library

Like

About the speaker

Doctor Xiaoyan Li

Princeton (United States of America)
0 follower

10 more presentations in this session

Age threshold for ischemic stroke risk in atrial fibrillation: cohort data covering the entire Korean population

Speaker: Assistant Professor H. Yu (Seoul, KR)

Access
Abstract
Like
Thumbnail

Antiplatelet therapy use in atrial fibrillation patients taking oral anticoagulation: an analysis of adverse outcomes from the FANTASIIA registry.

Speaker: Doctor M. Esteve Pastor (Murcia, ES)

Access
Abstract
Like
Thumbnail

Evaluation of appropriate use and clinical outcomes of idarucizumab as antidote of dabigatran in daily clinical practice

Speaker: Mr S. van der Wall (Haarlem, NL)

Access
Abstract
Slides
Like
Thumbnail

The new warfarin dosing algorithm for patients with atrial fibrillation and severe chronic kidney disease

Speaker: Doctor Z. Salpagarova (Moscow, RU)

Access
Abstract
Like
Thumbnail

Serum light-chain neurofilament, a brain lesion marker, correlates with CHA2DS2-VASc score among patients with atrial fibrillation: a cross-sectional study

Speaker: Doctor S. Aeschbacher (Basel, CH)

Access
Abstract
Like
Thumbnail

Access the full session

Poster Session 3 - Atrial fibrillation - Stroke prevention

Speakers: Doctor X. Li, Assistant Professor H. Yu, Doctor M. Esteve Pastor, Mr S. van der Wall, Doctor Z. Salpagarova...
Access
Like
Thumbnail

About the event

Image

ESC Congress 2018

25 August - 29 August 2018

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources